Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial.
Saved in:
| Title: | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. |
|---|---|
| Authors: | Harrison SA; Pinnacle Clinical Research, San Antonio, TX, USA., Ruane PJ; Ruane Clinical Research, Los Angeles, CA, USA., Freilich BL; Kansas City Research Institute, Kansas City, MO, USA., Neff G; Covenant Research, LLC, Sarasota, FL, USA., Patil R; South Texas Research Institute, Edinburg, TX, USA., Behling CA; NAFLD Research Center, Division of Gastroenterology, University of California, San Diego, San Diego CA, USA., Hu C; Medpace, Inc., Cincinnati, OH, USA., Fong E; Akero Therapeutics, South San Francisco, CA, USA., de Temple B; Akero Therapeutics, South San Francisco, CA, USA., Tillman EJ; Akero Therapeutics, South San Francisco, CA, USA., Rolph TP; Akero Therapeutics, South San Francisco, CA, USA., Cheng A; Akero Therapeutics, South San Francisco, CA, USA., Yale K; Akero Therapeutics, South San Francisco, CA, USA. kyale@akerotx.com. |
| Source: | Nature medicine [Nat Med] 2021 Jul; Vol. 27 (7), pp. 1262-1271. Date of Electronic Publication: 2021 Jul 08. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1546-170X |
|---|---|
| DOI: | 10.1038/s41591-021-01425-3 |
